Genetic susceptibility to infections with Aspergillus fumigatus

Critical Reviews in Microbiology

Volumn 36, Issue 2, 2010, Pages 168-177

  Mezger, Markus ^a   Einsele, Hermann ^a   Loeffler, Juergen ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Aspergillus fumigatus; Cytokines; Single nucleotide polymorphisms; Susceptibility; Toll like receptors

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CYTOKINE; CYTOKINE RECEPTOR; DECTIN 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MANNOSE BINDING LECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; B LYMPHOCYTE; CELL SURVIVAL; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GRANULOMATOSIS; HUMAN; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC;

ASPERGILLUS FUMIGATUS; CYTOMEGALOVIRUS;

EID: 77950677447     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/10408410903530619     Document Type: Review

References (63)

1. Allen MJ, Harbeck R, Smith B, Voelker DR, Mason RJ. (1999). Binding of rat and human surfactant proteins A and D to Aspergillus fumi-gatus conidia. Infect Immun, 67, 4563-4569.
2. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. (2000). TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet, 25, 187-191.
3. Asakura Y, Komatsu T. (2009). Toll-like receptor 4 polymorphisms and aspergillosis. N Engl J Med, 360, 635; author reply 635-635; author reply 636.
4. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ; Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. (2002). Defning opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis, 34, 7-14.
5. Bochud PY, Chien JW, Marr KA, Leisenring WM, Upton A, Janer M, Rodrigues SD, Li S, Hansen JA, Zhao LP, Aderem A, Boeckh M. (2008). Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med, 359, 1766-1777.
6. Brandt EB, Mingler MK, Stevenson MD, Wang N, Khurana Hershey GK, Whitsett JA, Rothenberg ME. (2008). Surfactant protein D alters allergic lung responses in mice and human subjects. J Allergy Clin Immunol 121, 1140-1147.
7. Brouard J, Knauer N, Boelle PY, Corvol H, Henrion-Caude A, Flamant C, Bremont F, Delaisi B, Duhamel JF, Marguet C, Roussey M, Miesch MC, Chadelat K, Boule M, Fauroux B, Ratjen F, Grasemann H, Clement A. (2005). Infuence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fbrosis. J Infect Dis, 191, 1988-1991.
8. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S. (2003). Dectin-1 mediates the biological efects of beta-glucans. J Exp Med, 197, 1119-1124.
9. Carvalho A, Cunha C, Carotti A, Aloisi T, Guarrera O, Di Ianni M, Falzetti F, Bistoni F, Aversa F, Pitzurra L, Rodrigues F, Romani L. (2009). Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. Exp Hematol, 37, 1022-1029.
10. Carvalho A, Pasqualotto AC, Pitzurra L, Romani L, Denning DW, Rodrigues F. (2008). Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis, 197, 618-621.
11. Cervera C, Moreno A, Lozano F. (2009). Toll-like receptor 4 polymorphisms and aspergillosis. N Engl J Med, 360, 634-5; author reply 635.
12. Choudhry S, Ung N, Avila PC, Ziv E, Nazario S, Casal J, Torres A, Gorman JD, Salari K, Rodriguez-Santana JR, Toscano M, Sylvia JS, Alioto M, Castro RA, Salazar M, Gomez I, Fagan JK, Salas J, Clark S, Lilly C, Matallana H, Selman M, Chapela R, Sheppard D, Weiss ST, Ford JG, Boushey HA, Drazen JM, Rodriguez-Cintron W, Silverman EK, Burchard EG. (2005). Pharmacogenetic diferences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med, 171, 563-570.
13. Crosdale DJ, Poulton KV, Ollier WE, Tomson W, Denning DW. (2001). Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis, 184, 653-656.
14. Einsele H, Hebart H. (2002). Cellular immunity to viral and fungal antigens after stem cell transplantation. Curr Opin Hematol, 9, 485-489.
15. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. (2003). Collaborative induction of infammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med, 197, 1107-1117.
16. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. (1984). Prolonged granulocytopenia, the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med, 100, 345-351.
17. Gibson PG. (2006). Allergic bronchopulmonary aspergillosis. Semin Respir Crit Care Med 27, 185-191.
18. Hebart H, Bollinger C, Fisch P, Sarfati J, Meisner C, Baur M, Loefer J, Monod M, Latgé JP, Einsele H. (2002). Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood, 100, 4521-4528.
19. Henderson SO, Haiman CA, Mack W. (2004). Multiple Polymorphisms in the renin-angiotensin-aldosterone system (ACE, CYP11B2, AGTR1) and their contribution to hypertension in African Americans and Latinos in the multiethnic cohort. Am J Med Sci, 328, 266-273.
20. Hollegaard M V, Bidwell JL. (2006). Cytokine gene polymorphism in human disease: on-line databases, Supplement 3. Genes Immun, 7, 269-276.
21. Hooper WC, Lally C, Austin H, Benson J, Dilley A, Wenger NK, Whitsett C, Rawlins P, Evatt BL. (1999). Te relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest, 116, 880-886.
22. Kaur S, Gupta VK, Shah A, Tiel S, Sarma PU, Madan T. (2006). Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol, 143, 414-419.
23. Kaur S, Gupta VK, Tiel S, Sarma PU, Madan T. (2007). Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Clin Exp Immunol, 148, 382-389.
24. Kesh S, Mensah NY, Peterlongo P, Jafe D, Hsu K, VAN DEN Brink M, O'reilly R, Pamer E, Satagopan J, Papanicolaou GA. (2005). TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann N Y Acad Sci, 1062, 95-103.
25. Kishore U, Greenhough TJ, Waters P, Shrive AK, Ghai R, Kamran MF, Bernal AL, Reid KB, Madan T, Chakraborty T. (2006). Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol, 43, 1293-1315.
26. Knutsen AP, Kariuki B, Consolino JD, Warrier MR. (2006). IL-4 alpha chain receptor. (IL-4Ralpha). polymorphisms in allergic bron-chopulmonary aspergillosis. Clin Mol Allergy 4, 3.
27. Lai CC, Liaw SJ, Lee LN, Hsiao CH, Yu CJ, Hsueh PR. (2007). Invasive pulmonary aspergillosis, high incidence of disseminated intra-vascular coagulation in fatal cases. J Microbiol Immunol Infect, 40, 141-147.
28. Latgé JP. (1999). Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev, 12, 310-350.
29. Latgé JP. (2001). Te pathobiology of Aspergillus fumigatus. Trends Microbiol, 9, 382-389.
30. Lee JE, Choi JH, Lee JH, Lee MG. (2005). Gene SNPs and mutations in clinical genetic testing: haplotype-based testing and analysis. Mutat Res, 573, 195-204.
31. Levitz SM, Shoham S, Cleary JD. (2009). Toll-like receptor 4 polymorphisms and aspergillosis. N Engl J Med, 360, 634; author reply 635-634; author reply 636.
32. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. (1996). Chemokine receptor specifc for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med, 184, 963-969.
33. Lundberg A, Wikberg LA, Ilonen J, Vaarala O, Böttcher MF. (2008). Lipopolysaccharide-induced immune responses in relation to the TLR4(Asp299Gly) gene polymorphism. Clin Vaccine Immunol, 15, 1878-1883.
34. Madan T, Kaur S, Saxena S, Singh M, Kishore U, Tiel S, Reid KB, Sarma PU. (2005). Role of collectins in innate immunity against aspergillosis. Med Mycol, 43 Suppl 1, S155-S163.
35. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. (2002). Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood, 100, 4358-4366.
36. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. (1997). Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet, 16, 100-103.
37. Meier A, Kirschning CJ, Nikolaus T, Wagner H, Heesemann J, Ebel F. (2003). Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol, 5, 561-570.
38. Mezger M, Stefens M, Beyer M, Manger C, Eberle J, Toliat MR, Wienker T F, Ljungman P, Hebart H, Dornbusch HJ, Einsele H, Loefer J. (2008). Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and infuence CXCL10 expression in monocyte-derived dendritic cells. Blood, 111, 534-536.
39. Morgan, J, Wannemuehler KA, Marr KA, Hadley S, Kontoyiannis DP, Walsh TJ, Fridkin SK, Pappas PG, Warnock DW. (2005). Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation, interim results of a prospective mul-ticenter surveillance program. Med Mycol, 43, 49-58.
40. Ott J. (1999). Analysis of human genetic linkage, 3rd edition. Johns Hopkins University Press, Baltimore MD.
41. Pamer EG. (2008). TLR polymorphisms and the risk of invasive fungal infections. N Engl J Med, 359, 1836-1838.
42. Paterson DL, Singh N. (1999). Invasive aspergillosis in transplant recipients. Medicine, 78, 123-138.
43. Roilides E, Dimitriadou-Georgiadou A, Sein T, Kadiltsoglou I, Walsh TJ. (1998). Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infect Immun, 66, 5999-6003.
44. Romani L. (2004). Immunity to fungal infections. Nat Rev Immunol, 4, 1-23.
45. Rösen-Wolf A, Soldan W, Heyne K, Bickhardt J, Gahr M, Roesler J. (2001). Increased susceptibility of a carrier of X-linked chronic granulomatous disease (CGD) to Aspergillus fumigatus infection associated with age-related skewing of lyonization. Ann Hematol, 80, 113-115.
46. Sainz J, Hassan L, Perez E, Romero A, Moratalla A, López- Fernández E, Oyonarte S, Jurado M. (2007a). Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis. Immunol Lett, 109, 76-82.
47. Sainz J, Pérez E, Gómez-Lopera S, Jurado M. (2008a). IL1 gene cluster polymorphisms and its haplotypes may predict the risk to develop invasive pulmonary aspergillosis and modulate C-reactive protein level. J Clin Immunol, 28, 473-485.
48. Sainz J, Pérez E, Gómez-Lopera S, López- Fernández E, Moratalla L, Oyonarte S, Jurado M. (2008b). Genetic variants of IL6 gene promoter infuence on C-reactive protein levels but are not associated with susceptibility to invasive pulmonary aspergillosis in haematological patients. Cytokine, 41, 268-278.
49. Sainz J, Pérez E, Hassan L, Moratalla A, Romero A, Collado MD, Jurado M. (2007b). Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis. Hum Immunol, 68, 41-50.
50. Sambatakou H, Pravica V, Hutchinson IV, Denning DW. (2006). Cytokine profling of pulmonary aspergillosis. Int J Immunogenet, 33, 297-302.
51. Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM. (2003). Te antifungal drug amphotericin B promotes infamma-tory cytokine release by a Toll-like receptor-and CD14-dependent mechanism. J Biol Chem, 278, 37561-37568.
52. Saxena S, Madan T, Shah A, Muralidhar K, Sarma PU. (2003). Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol, 111, 1001-1007.
53. Seo KW, Kim DH, Sohn SK, Lee NY, Chang HH, Kim SW, Jeon SB, Baek JH, Kim JG, Suh JS, Lee KB. (2005). Protective role of interleukin-10 promoter gene polymorphism in the pathogen-esis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transplant, 36, 1089-1095.
54. Stevens D. (2000). Aspergillosis, in Cecil textbook of medicine. Goldman BJ, ed., 1875-1877.
55. Stuart MJ, Nagel RL. (2004). Sickle-cell disease. Lancet, 364, 1343-1360.
56. Sun H, Ringdahl U, Homeister JW, Fay WP, Engleberg NC, Yang AY, Rozek LS, Wang X, Sjöbring U, Ginsburg D. (2004). Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science, 305, 1283-1286.
57. Tagore A, Gonsalkorale WM, Pravica V, Hajeer AH, McMahon R, Whorwell PJ, Sinnott PJ, Hutchinson IV. (1999). Interleukin-10 (IL-10) genotypes in infammatory bowel disease. Tissue Antigens, 54, 386-390.
58. Takahashi M, Iwaki D, Kanno K, Ishida Y, Xiong J, Matsushita M, Endo Y, Miura S, Ishii N, Sugamura K, Fujita T. (2008). Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. J Immunol, 180, 6132-6138.
59. Tong KB, Lau CJ, Murtagh K, Layton AJ, Seifeldin R. (2009). Te economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups. Int J Infect Dis, 13, 24-36.
60. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson I V. (1997). An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet, 24, 1-8.
61. Vaid M, Kaur S, Sambatakou H, Madan T, Denning DW, Sarma PU. (2007). Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Clin Chem Lab Med, 45, 183-186.
62. van der Graaf C, Kullberg BJ, Joosten L, Verver-Jansen T, Jacobs L, Van der Meer JW, Netea MG. (2005). Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism. Cytokine, 30, 264-268.
63. Zaas AK, Liao G, Chien JW, Weinberg C, Shore D, Giles SS, Marr KA, Usuka J, Burch LH, Perera L, Perfect JR, Peltz G, Schwartz DA. (2008). Plasminogen alleles infuence susceptibility to invasive aspergillosis. PLoS. Genet, 4, e1000101.